CME Group Inc (NASDAQ:CME) has received a consensus recommendation of “Hold” from the fifteen research firms that are presently covering the company, MarketBeat reports. Three research analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and five have given a buy recommendation to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $208.20.
Several research analysts have recently commented on the stock. Sanford C. Bernstein lowered shares of CME Group from an “outperform” rating to a “market perform” rating in a research note on Friday, January 10th. Deutsche Bank raised their price objective on shares of CME Group from $245.00 to $252.00 and gave the company a “buy” rating in a research note on Thursday, December 19th. Berenberg Bank lowered shares of CME Group from a “buy” rating to a “hold” rating and lowered their price objective for the company from $236.00 to $227.00 in a research note on Thursday, September 19th. BidaskClub raised shares of CME Group from a “hold” rating to a “buy” rating in a research note on Friday, January 10th. Finally, Citigroup raised their price objective on shares of CME Group from $220.00 to $240.00 and gave the company a “buy” rating in a research note on Monday, October 21st.
Shares of CME stock opened at $206.01 on Thursday. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.04 and a quick ratio of 1.04. The firm has a market cap of $72.95 billion, a PE ratio of 30.21, a price-to-earnings-growth ratio of 3.46 and a beta of 0.18. The company has a 50-day moving average of $203.77 and a two-hundred day moving average of $206.89. CME Group has a 1-year low of $161.05 and a 1-year high of $224.91.
CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 30th. The financial services provider reported $1.90 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.75 by $0.15. CME Group had a net margin of 40.93% and a return on equity of 9.54%. The company had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.27 billion. During the same quarter last year, the firm posted $1.45 earnings per share. CME Group’s revenue was up 41.3% compared to the same quarter last year. Sell-side analysts anticipate that CME Group will post 6.81 EPS for the current fiscal year.
The firm also recently disclosed a dividend, which was paid on Wednesday, January 15th. Stockholders of record on Friday, December 27th were paid a $2.50 dividend. This is a positive change from CME Group’s previous dividend of $1.75. The ex-dividend date of this dividend was Thursday, December 26th. CME Group’s dividend payout ratio (DPR) is presently 43.99%.
In related news, Director Martin J. Gepsman sold 1,000 shares of CME Group stock in a transaction that occurred on Friday, January 3rd. The shares were sold at an average price of $201.16, for a total value of $201,160.00. Following the completion of the transaction, the director now owns 34,905 shares in the company, valued at $7,021,489.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Ronald A. Pankau sold 300 shares of CME Group stock in a transaction that occurred on Thursday, November 7th. The stock was sold at an average price of $199.02, for a total transaction of $59,706.00. Following the completion of the transaction, the director now owns 3,906 shares of the company’s stock, valued at approximately $777,372.12. The disclosure for this sale can be found here. Insiders sold 40,609 shares of company stock valued at $8,216,221 in the last quarter. 1.20% of the stock is owned by insiders.
Hedge funds have recently added to or reduced their stakes in the business. Evoke Wealth LLC acquired a new stake in CME Group during the third quarter worth approximately $27,000. Thor Advisors LLC acquired a new position in shares of CME Group in the 3rd quarter valued at $34,000. Venturi Wealth Management LLC acquired a new position in shares of CME Group in the 3rd quarter valued at $36,000. Bartlett & Co. LLC increased its holdings in shares of CME Group by 2,471.4% in the 3rd quarter. Bartlett & Co. LLC now owns 180 shares of the financial services provider’s stock valued at $38,000 after acquiring an additional 173 shares during the period. Finally, Independence Bank of Kentucky acquired a new position in shares of CME Group in the 3rd quarter valued at $40,000. 84.14% of the stock is currently owned by institutional investors.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Featured Article: Why are analyst ratings important in trading stocks?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.